Inspirnaincis A Clinical Stage Biopharmaceutical Company Based In New York Citythe Company Focuses On Discovering And Developing Innovative Cancer Drugs That Address Significant Unmet Medical Needsinspirna Aims To Make Cancer A Manageable Condition By Utilizing Insights From Rna Biologyits Proprietary Mirna Driver Platform Helps Identify New Cancer Drivers And Actionable Targets Through Microrna Profiling The Company Has Several Drug Candidates In Its Pipelineompenaclidrgx 202Is An Orally Administered Small Molecule Currently In Phase 2 Development For Ras Mutant Colorectal Cancerabequolixronrgx 104Is In Phase 1B 2 Development For Lung And Endometrial Cancersbeing Tested In Collaboration With Bristol Myers Squibbadditionallyrgx 019 Adc Is A Novel Antibody Drug Conjugate Targeting Multiple Tumor Typesinspirna S Expertise In Rna Biology And Microrna Mapping Positions It As A Leader In Cancer Drug Development
No conferences found for this company.
| Company Name | Rgenix Inc |
| Country |
United States
|
| Address | 310 E 67th St Suite 1 12 New York Ny |
| Telephone | Login to View |
| Login to View |
